Targeting Inflammation to Prevent Bronchopulmonary Dysplasia: Can New Insights Be Translated Into Therapies?
- 1 July 2011
- journal article
- review article
- Published by American Academy of Pediatrics (AAP)
- Vol. 128 (1), 111-126
- https://doi.org/10.1542/peds.2010-3875
Abstract
Bronchopulmonary dysplasia (BPD) frequently complicates preterm birth and leads to significant long-term morbidity. Unfortunately, few therapies are known to effectively prevent or treat BPD. Ongoing research has been focusing on potential therapies to limit inflammation in the preterm lung. In this review we highlight recent bench and clinical research aimed at understanding the role of inflammation in the pathogenesis of BPD. We also critically assess currently used therapies and promising developments in the field.Keywords
This publication has 160 references indexed in Scilit:
- Hyperoxia-derived lung damage in preterm infantsSeminars in Fetal and Neonatal Medicine, 2010
- Detection of bone marrow–derived lung epithelial cellsExperimental Hematology, 2010
- Ureaplasma Species: Role in Diseases of PrematurityClinics in Perinatology, 2010
- Recent advances and new opportunities in lung mechanobiologyJournal of Biomechanics, 2010
- Prevention of bronchopulmonary dysplasiaSeminars in Fetal and Neonatal Medicine, 2009
- Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infantsAmerican Journal of Obstetrics and Gynecology, 2009
- Postnatal Corticosteroids for Bronchopulmonary DysplasiaClinics in Perinatology, 2009
- Shared Principles in NF-κB SignalingCell, 2008
- Epidemiology and causes of preterm birthThe Lancet, 2008
- The Alabama Preterm Birth Study: Umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infantsAmerican Journal of Obstetrics and Gynecology, 2008